Results 1 to 10 of about 153,751 (149)

An analysis of direct and indirect costs in Hidradenitis Suppurativa. [PDF]

open access: yesSkin Health Dis, 2023
Abstract Background Hidradenitis Suppurativa (HS) is a chronic inflammatory skin condition with recurrent nodules and abscesses that culminate in purulent discharge and scarring. It has significant physical, psychological and financial impact.
Howard-James C, Tobin AM.
europepmc   +4 more sources

The direct and indirect costs of cardiovascular diseases in Brazil. [PDF]

open access: yesPLoS One, 2022
Objective To evaluate the direct and indirect costs of cardiovascular diseases (such as coronary heart disease and stroke) by sex and age group, attributed to the excessive consumption of salt, saturated fat and trans fat in Brazil. Materials and methods The data for estimating the Population Attributable Fraction (PAF) corresponding to the ...
de Araújo JM   +8 more
europepmc   +4 more sources

Direct and Indirect Costs of Diabetes in Brazil in 2016. [PDF]

open access: yesAnn Glob Health, 2022
The global economic burden of Diabetes mellitus (DM) is expected to reach US$ 745 billion in 2030. The growing prevalence of the disease, mainly type 2 diabetes, is the result of population aging, nutritional transition, which include growing rates of obesity and consumption of foods high in sugar and fat.
Pereda P   +3 more
europepmc   +5 more sources

An assessment of direct and indirect costs of dementia in Brazil

open access: yesPLoS ONE, 2018
To analyze costs associated with dementia based on a cross-sectional study in the Brazilian health system.Direct and indirect costs were estimated by conducting comprehensive interviews on the use of resources in a sample of 156 patients with dementia treated at an outpatient memory clinic of a tertiary hospital.
Ceres Ferretti   +2 more
exaly   +5 more sources

Estimation of direct and indirect costs associated with obesity treatment interventions among adult populations in Iran. [PDF]

open access: yesBMC Health Serv Res
Background The prevalence of obesity worldwide has reached pandemic levels and is anticipated to escalate swiftly in developing nations. Given the substantial surge in obesity rates observed over the last three decades, assessing obesity-related costs is
Sharif FV   +3 more
europepmc   +2 more sources

One-year direct and indirect costs of ischaemic stroke in China. [PDF]

open access: yesStroke Vasc Neurol
Background This is the first real-world study to estimate the direct costs and indirect costs of first-ever ischaemic stroke with 1-year follow-up in China, based on a nationally representative sample.Methods Patients were chosen from 20 geographically ...
Lv W   +12 more
europepmc   +2 more sources

Direct and indirect costs of paediatric asthma in the UK: a cost analysis. [PDF]

open access: yesArch Dis Child
Objective To estimate the cost of paediatric asthma from a UK National Health Service (NHS) and societal perspective and explore determinants of these costs. Design
Kennedy CT   +3 more
europepmc   +4 more sources

The direct and indirect costs of adult atopic dermatitis. [PDF]

open access: yesJ Manag Care Spec Pharm, 2021
BACKGROUND: Atopic dermatitis is considered a childhood illness, and the direct and indirect health care burden of atopic dermatitis in adults is not fully understood. OBJECTIVE: To measure the direct and indirect costs of atopic dermatitis among adults in 2018.
Manjelievskaia J   +6 more
europepmc   +4 more sources

Analysis of direct, indirect, and intangible costs of epilepsy

open access: yesNeurología (English Edition), 2011
A financial estimate has been made of the costs of epilepsy in adults.A prospective, observational study, over a period of 6 months, on epileptic patients over 14 years-old. Patients with concomitant diseases that could influence the outcome of the epilepsy were excluded.
A. Pato Pato   +5 more
openaire   +4 more sources

Impact on direct and indirect costs of switching patients with inflammatory bowel disease from intravenous to subcutaneous infliximab (CT-P13). [PDF]

open access: yesBMJ Open Gastroenterol, 2023
Background We aim to compare the real-life direct and indirect costs of switching patients from intravenous to subcutaneous (SC) CT-P13, an infliximab biosimilar, in a tertiary UK Inflammatory Bowel Disease (IBD) centre.Methods All adult patients with ...
Carbery I   +6 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy